Nu Skin Enterprises, Inc. (NUS) Shares Sold by State Board of Administration of Florida Retirement System

State Board of Administration of Florida Retirement System lessened its position in Nu Skin Enterprises, Inc. (NYSE:NUS) by 0.6% in the first quarter, HoldingsChannel.com reports. The firm owned 77,339 shares of the company’s stock after selling 500 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Nu Skin Enterprises were worth $3,701,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Teachers Advisors LLC boosted its stake in shares of Nu Skin Enterprises by 19.8% in the 3rd quarter. Teachers Advisors LLC now owns 278,107 shares of the company’s stock valued at $22,922,000 after purchasing an additional 45,905 shares in the last quarter. Bank of Montreal Can boosted its stake in shares of Nu Skin Enterprises by 676.3% in the 4th quarter. Bank of Montreal Can now owns 69,583 shares of the company’s stock valued at $4,268,000 after purchasing an additional 60,620 shares in the last quarter. Strs Ohio boosted its stake in shares of Nu Skin Enterprises by 10.3% in the 4th quarter. Strs Ohio now owns 5,173 shares of the company’s stock valued at $317,000 after purchasing an additional 483 shares in the last quarter. Arizona State Retirement System lifted its position in Nu Skin Enterprises by 1.1% during the 4th quarter. Arizona State Retirement System now owns 39,870 shares of the company’s stock worth $2,445,000 after buying an additional 441 shares in the last quarter. Finally, Dynamic Advisor Solutions LLC acquired a new position in Nu Skin Enterprises during the 4th quarter worth about $332,000. Institutional investors own 75.03% of the company’s stock.

Shares of NYSE NUS opened at $49.78 on Friday. The stock has a market cap of $2.76 billion, a P/E ratio of 14.14, a P/E/G ratio of 1.18 and a beta of 0.67. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.10 and a current ratio of 1.86. Nu Skin Enterprises, Inc. has a 12-month low of $44.36 and a 12-month high of $88.68.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $0.77 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.06. The business had revenue of $623.60 million for the quarter, compared to the consensus estimate of $615.98 million. Nu Skin Enterprises had a net margin of 4.82% and a return on equity of 26.81%. The firm’s quarterly revenue was up 1.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.79 EPS. On average, sell-side analysts forecast that Nu Skin Enterprises, Inc. will post 3.92 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Friday, May 31st will be given a dividend of $0.37 per share. The ex-dividend date is Thursday, May 30th. This represents a $1.48 dividend on an annualized basis and a yield of 2.97%. Nu Skin Enterprises’s payout ratio is presently 42.05%.

NUS has been the topic of several research reports. Bank of America reiterated an “underperform” rating and set a $57.00 price target (up previously from $52.00) on shares of Nu Skin Enterprises in a research report on Wednesday, May 1st. ValuEngine downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Wednesday, March 20th. Pivotal Research reiterated a “buy” rating and set a $85.00 price target on shares of Nu Skin Enterprises in a research report on Wednesday, March 13th. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating in a research report on Friday, May 3rd. Finally, Stifel Nicolaus downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating and reduced their price target for the stock from $63.00 to $43.00 in a research report on Monday, March 25th. Three research analysts have rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $73.75.

COPYRIGHT VIOLATION WARNING: This news story was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.baseballdailydigest.com/news/2019/05/25/nu-skin-enterprises-inc-nus-shares-sold-by-state-board-of-administration-of-florida-retirement-system.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Read More: Recession

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.